跳至主要内容
临床试验/NCT06023654
NCT06023654已完成不适用

Preliminary Validation of a Novel Screening Tool and Diagnostic Criteria to Identify Circadian Rest-Activity Rhythm Disorders in Patients With Advanced Cancer

University of Dublin, Trinity College2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2023年5月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
2
主要终点
To measure preliminary concurrent validity of a novel screening tool to identify Circadian rest-Activity Rhythm Disorders in patients with advanced cancer against diagnostic criteria

研究概览

简要总结

Circadian rest-Activity Rhythm disorders (CARDs) are common in patients with cancer, particularly in advanced disease. CARDs are associated with increased symptoms, poorer quality of life, poorer response to anticancer treatments and shorter survival.

The goal of this observational study is to see how common CARDs are in patients with advanced cancer and to characterise their rest and activity patterns in more detail.

A recent study has outlined a standard way to assess and diagnose a CARD.

This study aims to assess patients with advanced cancer for a CARD using a novel screening tool against this newly formed diagnostic criteria. Potentially modifiable risk factors will be considered along with associations between CARDs and symptoms, sleep preferences, sleep quality, daytime sleepiness, quality of life measures and predictors of survival.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult (18 years of age or older)
  • Locally advanced or metastatic cancer
  • Outpatient
  • Ambulatory
  • Prognosis of 3 months or more

排除标准

  • Inpatient
  • Shiftworker
  • Recent long-haul travel
  • Cognitive impairment impacting on ability to complete questionnaires

结局指标

主要结局

To measure preliminary concurrent validity of a novel screening tool to identify Circadian rest-Activity Rhythm Disorders in patients with advanced cancer against diagnostic criteria

时间窗: Time 1 (baseline), Time 2 (after 72 consecutive hours of accelerometry monitoring)

Assessing the sensitivity and specificity of the screening tool

次要结局

  • To assess the relationship between past medical history and the risk of developing a Circadian rest-Activity Rhythms in patients with cancer(Time 2 (after 72 consecutive hours of accelerometry monitoring))
  • To measure acceptability and ease of use of a novel screening tool to identify Circadian rest-Activity Rhythm Disorders in patients with advanced cancer(Time 2 (after 72 consecutive hours of accelerometry monitoring))
  • To assess rest and physical activity patterns in patients with advanced cancer(Time 2 (after 72 consecutive hours of accelerometry monitoring))
  • To measure test-retest reliability of a novel screening tool to identify Circadian rest-Activity Rhythm Disorders in patients with advanced cancer(Time 1 (baseline), Time 2 (after 72 consecutive hours of accelerometry monitoring))
  • To identify the incidence of Circadian rest-activity Rhythm Disorders in patients with advanced cancer(Time 2 (after 72 consecutive hours of accelerometry monitoring))
  • To measure acceptability and ease of use of a novel sleep and activity diary in patients with advanced cancer(Time 2 (after 72 consecutive hours of accelerometry monitoring))
  • To assess the relationship between demographic details and the risk of developing a Circadian rest-Activity Rhythms in patients with cancer(Time 2 (after 72 consecutive hours of accelerometry monitoring))
  • To assess associations between Circadian rest-activity Rhythm Disorders in patients with advanced cancer with quality of life(Time 2 (after 72 consecutive hours of accelerometry monitoring))
  • To assess associations between Circadian rest-activity Rhythm Disorders in patients with advanced cancer with sleep quality(Time 2 (after 72 consecutive hours of accelerometry monitoring))
  • To assess associations between Circadian rest-activity Rhythm Disorders in patients with advanced cancer with daytime sleepiness(Time 2 (after 72 consecutive hours of accelerometry monitoring))
  • To assess the relationship between chronotype and the risk of develop a Circadian rest-Activity Rhythms in patients with cancer(Time 2 (after 72 consecutive hours of accelerometry monitoring))
  • To assess associations between Circadian rest-activity Rhythm Disorders in patients with advanced cancer and prognosis(Time 2 (after 72 consecutive hours of accelerometry monitoring))
  • To assess the relationship between occupation and the risk of developing a Circadian rest-Activity Rhythms in patients with cancer(Time 2 (after 72 consecutive hours of accelerometry monitoring))
  • To assess the relationship between alcohol consumption and the risk of developing a Circadian rest-Activity Rhythms in patients with cancer(During 72 hours period of monitoring)
  • To assess associations between Circadian rest-activity Rhythm Disorders in patients with advanced cancer with symptoms(Time 2 (after 72 consecutive hours of accelerometry monitoring))
  • To assess the relationship between caffeine consumption and the risk of developing a Circadian rest-Activity Rhythms in patients with cancer(During 72 hours period of monitoring)
  • To assess the relationship between current medication use and the risk of developing a Circadian rest-Activity Rhythms in patients with cancer(Time 2 (after 72 consecutive hours of accelerometry monitoring))
  • To assess the relationship between cigarette use and the risk of developing a Circadian rest-Activity Rhythms in patients with cancer(During 72 hours period of monitoring)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Prof Andrew Davies

Professor of Palliative Medicine

University of Dublin, Trinity College

研究点 (2)

Loading locations...

相似试验